Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Lilly Grant Registry Goes Online, Shows $12 Million Dispensed In First Quarter

  • News

Executive Summary

Education providers received the largest amount of funding from Lilly - approximately $4.8 million - in the first quarter, the firm's grant registry shows

You may also be interested in...



Pfizer Matches Lilly In Grant Spending For 1st Quarter; Fibromyalgia Is Focus

Pfizer and Lilly dispensed comparable amounts in grants during the first quarter of 2008, as revealed by Pfizer's inaugural online posting of gifts and charitable donations, unveiled May 15

Pfizer Matches Lilly In Grant Spending For 1st Quarter; Fibromyalgia Is Focus

Pfizer and Lilly dispensed comparable amounts in grants during the first quarter of 2008, as revealed by Pfizer's inaugural online posting of gifts and charitable donations, unveiled May 15

AstraZeneca In The “Transparency” Era: An Interview With CEO David Brennan

If you visit AstraZeneca's offices in Washington, D.C., your name has to be on a list. After you get your badge, you show it at the elevator bank to a guard, who, in a throwback to operators of yore, steps inside with you to unlock the keypad and send you on your way

Table

View full table

Tags:
Latest Headlines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds

Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing

Global Pharma Guidance Tracker – March 2024

See All
UsernamePublicRestriction

Register

PS048355

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By